Contrastive multimodal learning significantly enhances survival prediction in grade 2/3 gliomas by effectively integrating histopathology, genomics, and clinical data. This annotation-free approach enables early risk stratification using routinely collected data and shows promise for informing personalized treatment decisions and clinical trial stratification.
Hua et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: